# Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy

> **NCT01140776** · — · TERMINATED · sponsor: **Sysmex America, Inc.** · enrollment: 100 (estimated)

## Conditions studied

- Breast Neoplasms
- Breast Diseases

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01140776
- **Lead sponsor:** Sysmex America, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2012-07
- **Final completion:** 2012-07
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2011-06-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01140776

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01140776, "Clinical Evaluation of OSNA Breast Cancer System in Breast Cancer Patients Receiving Neoadjuvant Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01140776. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*